Neither Mochi nor Remedy Meds manufactures medications themselves
GLP-1 receptor agonists and cardiovascular disease in patients with type 2 diabetes
[DOI] [PubMed] [Google Scholar] 20.Marso SP, Bain SC, Consoli A, et al
Fallows additionally pointed out that, although obesity is often thought of as a case of being over-nourished, the opposite is frequently true, with muscle wasting and nutrient deficiencies being just as common in these individuals as in those who are underweight
Because GLP-1 medications cause people to eat less overall, they consume fewer micronutrients
its availability for weight management on the NHS is subject to separate NICE guidance patients should check the latest NICE publications or speak to their clinician for current eligibility